Expert recommendations on blood purification treatment protocol for patients with severe COVID-19
Coronavirus disease (COVID-19) was first diagnosed in Wuhan in December 2019. The World Health Organization defined the subsequent outbreak of COVID-19 worldwide as a public health emergency of international concern. Epidemiological data indicate that at least 20% of COVID-19 patients have severe di...
Guardado en:
Autores principales: | Xiang-Hong Yang, Ren-Hua Sun, Ming-Yan Zhao, Er-Zhen Chen, Jiao Liu, Hong-Liang Wang, Rong-Li Yang, De-Chang Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/06810ccab53d49149b1c0067fe2b3803 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021
por: Jonathan Mandolo, et al.
Publicado: (2021) -
Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
por: Ravi Kant, et al.
Publicado: (2021) -
Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
por: Ángel Estella, et al.
Publicado: (2021) -
La Saliva como Biomuestra para Diagnóstico de Infección por SARS-CoV-2: Una Revisión
por: Morales-Espinosa,Rolando
Publicado: (2020) -
Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS
por: Lili Zhao, et al.
Publicado: (2021)